ASR three-lens brief
Evidence-based stock research on ASR. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Outperforming SPY by 15.9pp over 30 days. · RSI at 71 — technically overbought.
- RSI at 71 — technically overbought.
- Outperforming SPY by 15.9pp over 30 days.
- Analyst mean target $324.22 — 19% above current (9 analysts).
- Negative free cash flow last quarterly (-$1.94B).
ASR closed at $271.71 (+1.23%) as of 2026-11-12. Market cap: $8.16B. P/E (trailing) 14.4. Price is above the 50-day MA and below the 200-day MA. Positives: outperforming SPY by 15.9pp over 30 days.; analyst mean target $324.22 — 19% above current (9 analysts).. Concerns: rSI at 71 — technically overbought.; negative free cash flow last quarterly (-$1.94B).. Last quarter: Revenue $10.42B, net income $2.16B, free cash flow -$1.94B.
Why three lenses on ASR, not one.
A single reasoning model has blind spots it doesn’t know about. We examine ASR across Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://www.clearpathinvest.app/embed/ASR" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath ASR brief"></iframe>